DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Information source: University Hospital, Geneva
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy; Immunosuppressed; Asthmatic; Neuromuscular Diseases

Phase: N/A

Status: Completed

Sponsored by: University Hospital, Geneva

Official(s) and/or principal investigator(s):
Klara M Posfay-Barbe, MD, MS, Principal Investigator, Affiliation: University Hospitals of Geneva


This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Clinical Details

Official title: Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: ABCB1 polymorphisms


Minimum age: N/A. Maximum age: 16 Years. Gender(s): Both.


Inclusion Criteria:

- suspicion of H1N1 infection

Exclusion Criteria:

- Not available for a 30 days follow-up

Locations and Contacts

Children's Hospital of Geneva, HUG, Geneva, GE 1211, Switzerland
Additional Information

Starting date: October 2009
Last updated: December 10, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017